Literature DB >> 9669078

A new approach to surgery for Menière's disease: talking about surgery.

A G Kerr1, J G Toner.   

Abstract

Many patients experience a remission of their Menière's disease between the time that surgery is agreed and their admission to hospital for the procedure. In a series of 23 consecutive patients where surgery appeared to be indicated for control of the vertigo of Menière's disease, 12 settled within 6-8 weeks of agreeing that something would be done, and thereby avoided any surgical procedure. It is suggested that these patients may have been experiencing the same effect as provided by the conservative surgical procedures. In the absence of any clear evidence for a specific surgical effect from any conservative operation for Menière's disease, the authors put forward the suggestion that abandoning all the conservative procedures in favour of the protocol of planned surgery should be considered; wait for 2 months and, if the incapacitating episodic dizziness continues, one should proceed to a differenting procedure.

Entities:  

Mesh:

Year:  1998        PMID: 9669078     DOI: 10.1046/j.1365-2273.1998.00153.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  5 in total

Review 1.  Menière's disease.

Authors:  Tony Wright
Journal:  BMJ Clin Evid       Date:  2015-11-05

Review 2.  The inner ear and the neurologist.

Authors:  Charlotte Agrup; Michael Gleeson; Peter Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

Review 3.  Menière's disease.

Authors:  Adrian L James; Marc A Thorp
Journal:  BMJ Clin Evid       Date:  2007-03-01

Review 4.  Issues, indications, and controversies regarding intratympanic steroid perfusion.

Authors:  Mohamed Hamid; Dennis Trune
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 2.064

5.  Surgical indication in Menière's disease therapy: clinical and epidemiological aspects.

Authors:  Roberto Albera; Andrea Canale; Fiorella Parandero; Alessandro Ducati; Michele Lanotte
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-19       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.